Join the Fight Against MDS

Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.

August 7, 2021

Outcomes for High-Risk MDS Patients Undergoing Transplant vs Standard Non-Transplant Therapies

This webinar will provide an overview of the role of allogeneic hematopoietic cell transplantation (alloHCT) for high-risk MDS patients. Standard therapies for patients with MDS including hypomethylating agents (HMAs) and a variety of novel agents outside of allogeneic HCT will be discussed.

Speaker

EW

Erica D. Warlick, MD

Presentation Recordings

Access to the meeting presentations are available below by clicking on each topic.

Our Supporters

Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, Acceleron, and Gamida Cell for supporting this initiative.

The MDS Foundation proudly partners with the following organizations

MDS AllianceKnow AMLALANThe NHLBI Blood Health Network

Get in touch

Email

support@mds-foundation.org
hcp@mds-foundation.org

Phone within the US

1-(800)-637-0839

Outside the US only

1-(609)-298-1035

Address

The MDS Foundation
228 Park Ave S
PMB 118983
New York
NY 10003-1502

Guide Star Platinum

The MDS Foundation is a global nonprofit 501(c)(3) advocacy organization (EIN 22-3283911), supporting patients, families, and healthcare providers in the fields of MDS and related diseases for over 30 years.

© 2024 MDS Foundation. All rights reserved.